首页/数据集/Proteins with nominal evidence for change (unadjusted p<0.05) during treatment of the protein array cohort (n=22 patients).

Proteins with nominal evidence for change (unadjusted p<0.05) during treatment of the protein array cohort (n=22 patients).

Figshare2018-12-28 更新2026-04-29 收录

临床蛋白质组学

治疗反应生物标志物

数据链接：

https://figshare.com/articles/dataset/Proteins_with_nominal_evidence_for_change_unadjusted_p_0_05_during_treatment_of_the_protein_array_cohort_n_22_patients_/7530407 数据链接链接失效反馈

官方服务：

资源简介：

Proteins with nominal evidence for change (unadjusted p

应用场景：

创建时间：

2018-12-28

临床蛋白质组学

口腔癌生物标志物

Fig. s1: XIC peak areas (mean ± SD) of salivary cystatins (a), histatins (b), bPRPs (c) analysed in the acid-soluble fraction of resting whole saliva (1), stimulated whole saliva (2), parotid saliva

NIAID Data Ecosystem30

Comprehensive Urinary Proteome Profiling Analysis Identifies Diagnosis and Relapse Surveillance Biomarkers for Bladder Cancer

癌症生物标志物

临床蛋白质组学

Bladder cancer (BCa) is the predominant malignancy of the urinary system. Herein, a comprehensive urine proteomic feature was initially established for the noninvasive diagnosis and recurrence monitor

Figshare2024-05-24 更新10

A network-based framework to discover treatment-response-predicting biomarkers for complex diseases. A network-based framework to discover treatment-response-predicting biomarkers for complex diseases

治疗反应生物标志物

自身免疫性疾病精准医疗

Precision medicine's potential to transform complex autoimmune-disease treatment is often challenged by limited data availability and inadequate sample size when compared to the number of molecular fe

NIAID Data Ecosystem00

Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

临床蛋白质组学

多囊肾病诊断

Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely become available in the near future, hence reliable diagnostic and prognostic biomarkers for the disease are stro

Figshare2016-01-19 更新10

Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial

创伤（医学与心理）

临床蛋白质组学

Denver Health has conducted the Control of Major Bleeding After Trauma (COMBAT) clinical research study, which aimed to improve trauma care for all patients (https://www.denverhealth.org/services/trau

NIAID Data Ecosystem10

Proteins with nominal evidence for change (unadjusted p<0.05) during treatment of the protein array cohort (n=22 patients).

资源简介：

相关数据集